Innovative diagnostic tools for early detection of Alzheimer's disease

Christoph Laske, Hamid R. Sohrabi, Shaun M. Frost, Karmele López-De-Ipiña, Peter Garrard, Massimo Buscema, Justin Dauwels, Surjo R. Soekadar, Stephan Mueller, Christoph Linnemann, Stephanie A. Bridenbaugh, Yogesan Kanagasingam, Ralph N. Martins, Sid E. O'bryant

Research output: Contribution to journalReview article

97 Citations (Scopus)

Abstract

Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal fluid analysis), expensive (neuroimaging) and time-consuming (neuropsychological assessment) and thus have limited accessibility as frontline screening and diagnostic tools for AD. Thus, there is an increasing need for additional noninvasive and/or cost-effective tools, allowing identification of subjects in the preclinical or early clinical stages of AD who could be suitable for further cognitive evaluation and dementia diagnostics. Implementation of such tests may facilitate early and potentially more effective therapeutic and preventative strategies for AD. Before applying them in clinical practice, these tools should be examined in ongoing large clinical trials. This review will summarize and highlight the most promising screening tools including neuropsychometric, clinical, blood, and neurophysiological tests.

Original languageEnglish
Pages (from-to)561-578
Number of pages18
JournalAlzheimer's and Dementia
Volume11
Issue number5
DOIs
StatePublished - 1 May 2015

Fingerprint

Early Diagnosis
Alzheimer Disease
Hematologic Tests
Neuroimaging
Cerebrospinal Fluid
Dementia
Clinical Trials
Costs and Cost Analysis
Therapeutics

Keywords

  • Alzheimer's disease
  • Diagnostic tools
  • Early detection
  • Noninvasive tests
  • Screening tests

Cite this

Laske, C., Sohrabi, H. R., Frost, S. M., López-De-Ipiña, K., Garrard, P., Buscema, M., ... O'bryant, S. E. (2015). Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimer's and Dementia, 11(5), 561-578. https://doi.org/10.1016/j.jalz.2014.06.004
Laske, Christoph ; Sohrabi, Hamid R. ; Frost, Shaun M. ; López-De-Ipiña, Karmele ; Garrard, Peter ; Buscema, Massimo ; Dauwels, Justin ; Soekadar, Surjo R. ; Mueller, Stephan ; Linnemann, Christoph ; Bridenbaugh, Stephanie A. ; Kanagasingam, Yogesan ; Martins, Ralph N. ; O'bryant, Sid E. / Innovative diagnostic tools for early detection of Alzheimer's disease. In: Alzheimer's and Dementia. 2015 ; Vol. 11, No. 5. pp. 561-578.
@article{c6ddd6192a534667885362b304102a27,
title = "Innovative diagnostic tools for early detection of Alzheimer's disease",
abstract = "Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal fluid analysis), expensive (neuroimaging) and time-consuming (neuropsychological assessment) and thus have limited accessibility as frontline screening and diagnostic tools for AD. Thus, there is an increasing need for additional noninvasive and/or cost-effective tools, allowing identification of subjects in the preclinical or early clinical stages of AD who could be suitable for further cognitive evaluation and dementia diagnostics. Implementation of such tests may facilitate early and potentially more effective therapeutic and preventative strategies for AD. Before applying them in clinical practice, these tools should be examined in ongoing large clinical trials. This review will summarize and highlight the most promising screening tools including neuropsychometric, clinical, blood, and neurophysiological tests.",
keywords = "Alzheimer's disease, Diagnostic tools, Early detection, Noninvasive tests, Screening tests",
author = "Christoph Laske and Sohrabi, {Hamid R.} and Frost, {Shaun M.} and Karmele L{\'o}pez-De-Ipi{\~n}a and Peter Garrard and Massimo Buscema and Justin Dauwels and Soekadar, {Surjo R.} and Stephan Mueller and Christoph Linnemann and Bridenbaugh, {Stephanie A.} and Yogesan Kanagasingam and Martins, {Ralph N.} and O'bryant, {Sid E.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.jalz.2014.06.004",
language = "English",
volume = "11",
pages = "561--578",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "5",

}

Laske, C, Sohrabi, HR, Frost, SM, López-De-Ipiña, K, Garrard, P, Buscema, M, Dauwels, J, Soekadar, SR, Mueller, S, Linnemann, C, Bridenbaugh, SA, Kanagasingam, Y, Martins, RN & O'bryant, SE 2015, 'Innovative diagnostic tools for early detection of Alzheimer's disease', Alzheimer's and Dementia, vol. 11, no. 5, pp. 561-578. https://doi.org/10.1016/j.jalz.2014.06.004

Innovative diagnostic tools for early detection of Alzheimer's disease. / Laske, Christoph; Sohrabi, Hamid R.; Frost, Shaun M.; López-De-Ipiña, Karmele; Garrard, Peter; Buscema, Massimo; Dauwels, Justin; Soekadar, Surjo R.; Mueller, Stephan; Linnemann, Christoph; Bridenbaugh, Stephanie A.; Kanagasingam, Yogesan; Martins, Ralph N.; O'bryant, Sid E.

In: Alzheimer's and Dementia, Vol. 11, No. 5, 01.05.2015, p. 561-578.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Innovative diagnostic tools for early detection of Alzheimer's disease

AU - Laske, Christoph

AU - Sohrabi, Hamid R.

AU - Frost, Shaun M.

AU - López-De-Ipiña, Karmele

AU - Garrard, Peter

AU - Buscema, Massimo

AU - Dauwels, Justin

AU - Soekadar, Surjo R.

AU - Mueller, Stephan

AU - Linnemann, Christoph

AU - Bridenbaugh, Stephanie A.

AU - Kanagasingam, Yogesan

AU - Martins, Ralph N.

AU - O'bryant, Sid E.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal fluid analysis), expensive (neuroimaging) and time-consuming (neuropsychological assessment) and thus have limited accessibility as frontline screening and diagnostic tools for AD. Thus, there is an increasing need for additional noninvasive and/or cost-effective tools, allowing identification of subjects in the preclinical or early clinical stages of AD who could be suitable for further cognitive evaluation and dementia diagnostics. Implementation of such tests may facilitate early and potentially more effective therapeutic and preventative strategies for AD. Before applying them in clinical practice, these tools should be examined in ongoing large clinical trials. This review will summarize and highlight the most promising screening tools including neuropsychometric, clinical, blood, and neurophysiological tests.

AB - Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal fluid analysis), expensive (neuroimaging) and time-consuming (neuropsychological assessment) and thus have limited accessibility as frontline screening and diagnostic tools for AD. Thus, there is an increasing need for additional noninvasive and/or cost-effective tools, allowing identification of subjects in the preclinical or early clinical stages of AD who could be suitable for further cognitive evaluation and dementia diagnostics. Implementation of such tests may facilitate early and potentially more effective therapeutic and preventative strategies for AD. Before applying them in clinical practice, these tools should be examined in ongoing large clinical trials. This review will summarize and highlight the most promising screening tools including neuropsychometric, clinical, blood, and neurophysiological tests.

KW - Alzheimer's disease

KW - Diagnostic tools

KW - Early detection

KW - Noninvasive tests

KW - Screening tests

UR - http://www.scopus.com/inward/record.url?scp=84929264128&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2014.06.004

DO - 10.1016/j.jalz.2014.06.004

M3 - Review article

C2 - 25443858

AN - SCOPUS:84929264128

VL - 11

SP - 561

EP - 578

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 5

ER -

Laske C, Sohrabi HR, Frost SM, López-De-Ipiña K, Garrard P, Buscema M et al. Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimer's and Dementia. 2015 May 1;11(5):561-578. https://doi.org/10.1016/j.jalz.2014.06.004